No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RENB Renovaro
- 1.445
- -0.005-0.34%
Trading Jun 20 10:06 ET
213.14MMarket Cap-1806P/E (TTM)
1.520High1.420Low68.06KVolume1.460Open1.450Pre Close100.39KTurnover0.06%Turnover RatioLossP/E (Static)147.50MShares5.25052wk High1.26P/B153.12MFloat Cap0.39352wk Low--Dividend TTM105.96MShs Float13.780Historical High--Div YieldTTM6.90%Amplitude0.393Historical Low1.475Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Renovaro(RENB.US) 10% Shareholder Sells US$79,000 in Common Stock
$Renovaro(RENB.US)$ 10% Shareholder William Anderson Wittekind sold 50,000 shares of common stock on Jun 14, 2024 at an average price of $1.58 for a total value of $79,000.Source: Announcement What is
12 Health Care Stocks Moving In Friday's After-Market Session
GainersKineta (NASDAQ:KA) shares moved upwards by 28.5% to $0.67 during Friday's after-market session. The company's market cap stands at $8.1 million. iSpecimen (NASDAQ:ISPC) stock moved upwards by 1
Express News | Renovaro, Inc. Announces $10 Million in Equity Committed
Form 144 | Renovaro(RENB.US) 10% Stockholder Proposes to Sell 1.74 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 11, $Renovaro(RENB.US)$ 10% Stockholder William Anderson Wittekind intends to sell 1.2 million shares of its common stock on May 30, with a total market value of approximat
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSeres Therapeutics (NASDAQ:MCRB) stock moved upwards by 34.0% to $0.82 during Monday's regular session. The company's market cap stands at $124.5 million. Renovaro (NASDAQ:RENB) shares increase
Comments
$Renovaro(RENB.US$ LOS ANGELES and AMSTERDAM, May 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ:RENB) and the Amsterdam UMC Cancer Center today announced an intended partnership and therefore signed an MoU to establish a joint company based in the Netherlands aimed at pioneering the next generation of personalized cancer immunotherapy. Both Renovaro and Amsterdam UMC emphasize the need to carry out the appropriate corporate and scientific due diligence before taking these next s...
1
$Renovaro(RENB.US$
NEWS
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
RenovaroCube acquires 100% ownership of Cyclomics, solidifying their collaboration in cancer diagnostics.
The partnership with Oxford Nanopore and Nvidia enhances RenovaroCube's capabilities in early cancer detection and treatment monitoring.
RenovaroCube's open architecture AI platform combined with Cyclomics' 4th generation molecular technology enables accurate ...
NEWS
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
RenovaroCube acquires 100% ownership of Cyclomics, solidifying their collaboration in cancer diagnostics.
The partnership with Oxford Nanopore and Nvidia enhances RenovaroCube's capabilities in early cancer detection and treatment monitoring.
RenovaroCube's open architecture AI platform combined with Cyclomics' 4th generation molecular technology enables accurate ...
Renovaro Inc.'s leadership foresees AI and biotech fusion revolutionizing healthcare, enhancing precision, effectiveness, and accessibility. They also predict faster detection and treatment of cancer and other diseases due to their combined capabilities.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg